These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7355530)

  • 21. [Studies on oxalate in urolithiasis. II. Urinary oxalate in oxalate stone-formers (author's transl)].
    Ogawa Y
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1546-52. PubMed ID: 7345192
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of calcium oxalate values as indicators of risk for calcium oxalate calcinosis and the degree of urine saturation in patients with calcium urolithiasis and in healthy patients].
    Głuszek J; Boruczkowska A; Kosicka T; Raszeja-Wanic B
    Pol Tyg Lek; 1989 Feb; 44(9):220-2. PubMed ID: 2813183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M
    Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diurnal variations of calcium, phosphorus, and magnesium in normal and calcium oxalate stone-forming urine.
    Ogawa Y; Kitagawa R; Umeyama T
    Nihon Jinzo Gakkai Shi; 1983 Sep; 25(9):1131-4. PubMed ID: 6686621
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
    Parent X; Boess G; Brignon P
    Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of urinary stone disease by physical exercise.
    Sriboonlue P; Prasongwatana V; Tosukhowong P; Tungsanga K; Bovornpadoongkitti S
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):172-7. PubMed ID: 9031423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in circadian rhythmicity in calcium oxalate renal stone formers.
    Touitou Y; Touitou C; Charransol G; Reinberg A; Thomas J; Bogdan A; Barthelemy C; Desgrez P
    Int J Chronobiol; 1983; 8(3):175-92. PubMed ID: 6862698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diurnal variation in calcium-oxalate supersaturation level in normal and stone-forming urine.
    Ogawa Y; Takahashi S; Kitagawa R; Umeyama T; Aoyagi K
    Nihon Jinzo Gakkai Shi; 1983 Sep; 25(9):1127-30. PubMed ID: 6686620
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evening urinary oxalate excretion in stone formers.
    Banks JG; Sullivan M; Hargreave TB
    Br J Urol; 1979 Oct; 51(5):349-51. PubMed ID: 533589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls].
    Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471
    [No Abstract]   [Full Text] [Related]  

  • 40. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.